A comparison of the safety and efficacy of the VenaBlock cyanoacrylate-based endovenous system versus 1470 nm endovascular biradial laser in the treatment of truncal insufficiency of superficial veins: six-month outcomes of the ESVETIS observational study

Wilczko, Justyna; Szary, Cezary; Plucińska, Dominika; Grzela, Tomasz

doi:10.5114/pr.2019.93402

Cited by 4 publications

(3 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the eSCOPE study, which included four European countries, the complete occlusion results rates with 3-year follow-up were 91.4%, 90.0%, 88.5% and 88.5% at the time points 6, 12, 24, and 36-month time points, respectively 49 . Similarly, VCSS and QoL Scores exhibited a statistically signi cant reduction in overtime with similar rates in modalities using EVTA or CAC [29][30][31]50,55,[59][60][61] . All studies recorded a signi cant reduction in Aberdeen Varicose Vein Questionnaire Score (AVVQ-S) after CAC applications, which is one of the evaluation methods for improvement in Quality of Life (QoL) Both products were found to be effective in terms of VCSS and AVVQ changes after applications compared to baseline values (Figs.…”

Section: Discussionmentioning

confidence: 99%

“…CAC studies reported varying rates of adverse events. However, in general consensus, CAC therapy has high e cacy and an acceptable low rate of adverse events [15][16][17]23,[25][26][27][28][29][30][31][38][39][40][41][42][43][44][45][46][47][48][49][50]66 . Venous thromboembolism has been reported at null or very low rates.…”

Section: Discussionmentioning

confidence: 99%

“…Although not FDA approved, due to some strict rules (such as being tested in the American population), VenaBlock (Invamed, Ankara, Turkey) is one of the widely used products. Many studies have been conducted to compare the clinical e cacy and safety of CAC systems with the other techniques [23][24][25][26][27][28][29][30][31][32][33][34][35] , however, no published study was found in the literature comparing different CAC systems [36][37][38][39] .…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Catheter-guided endovenous cyanoacrylate closure is effective and safe in chronic venous insufficiency of the lower extremity: A Comparative Analysis

Bozkurt,

Balkanay,

Dinc

2023

Preprint

View full text Add to dashboard Cite

Background Cyanoacrylate adhesive closure (CAC) systems have become widely used in the treatment of varicose veins. In terms of efficacy and safety, these non-thermal non-tumescent methods have been reported to be noninferior to endovenous thermal ablation techniques. There are no known published studies that compare products using CAC. VenaSeal® (Medtronic, Santa Rosa, Ca, USA) and VenaBlockⓇ (Invamed, Ankara, Turkey) are among the most commonly used CAC-based products worldwide. This review article focuses on the efficacy and safety of these two different commonly used products.Methods Published full-text research articles regarding the VenaBlock® System or the VenaSealⓇ System was searched. Data for each product were evaluated by comparing them with each other in terms of effectiveness and safety.Results A total of 1882 extremities from 11 studies with VenaBlock® and 524 extremities from 8 studies with VenaSealⓇ were included and compared. Both devices were observed to be effective and cumulative recanalization-free survival rates were similar (p = 0.188) at the 6th, 12th, 24th, 36th and 60th month follow-ups. Both products were found to improve VCSS and QoL scores.Conclusion Both devices were effective in terms of cumulative recanalization-free survival rates. Both significantly improved the venous clinical severity score and the quality of life scores. Cyanoacrylate adhesive closure is feasible in varicose vein treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Catheter-guided endovenous cyanoacrylate closure is effective and safe in chronic venous insufficiency of the lower extremity: A Comparative Analysis

Bozkurt,

Balkanay,

Dinc

2023

Preprint

View full text Add to dashboard Cite

show abstract

Endovenous glue ablation for chronic venous insufficiency: A comprehensive 5-year assessment of clinical and hemodynamic outcomes

Guven

2024

Vascular

View full text Add to dashboard Cite

Objectives Chronic venous insufficiency is mainly caused by reflux, obstruction, or both. Endovenous glue ablation has become one of the widely used methods for treating reflux in recent years. Duplex ultrasonography is the most commonly used method for diagnosing and evaluating treatment. However, there is important information that plethysmographic venous hemodynamics provides, which Duplex USG cannot provide. This retrospective study aimed to evaluate the 5-year clinical, anatomical, and hemodynamic results of endovenous glue ablation in the treatment of chronic venous insufficience, accompanied by the data from the plethysmographic study. Patients and Method Between January 2018 and August 2018, 133 patients with symptomatic CEAP 2-6 varicose veins with reflux of the great saphenous vein lasting longer than 0.5 seconds and a diameter of 5.5 mm in the standing great saphenous vein underwent EVGA. CEAP, VCSS, CIVIQ 20, Doppler USG, GSV diameters and insufficiency times, and hemodynamically Venous Refilling Time and Venous Half-Value Time measurements were performed before the procedure. In the same way, measurements were made at the 1st, 3rd, 6th, 12th, 24th, and 60th months of the patients who were called and came to the postoperative follow-up. Results Procedural success was 100%, and complete occlusion was observed %93 after treatment, at the 60 month. The improvement in VCSS (from 4.4 ± 1.3 to 1.7 ± 0.9), CIVIQ20 (from 8.5 ± 3.1 to 4.7 ± 2.0), VRT (from 20.3 ± 5.0 to 131.1 ± 4.0), and TH (from 2.8 ± 0.3 to 2.4 ± 0.2) was significant ( p < .001 was for all). Conclusion Endovenous glue ablation is a preferred method for the treatment of great saphenous vein insufficiency due to its ease of use and the comfort it provides to patients, as well as its effectiveness and safety. In particular, it can be considered an effective method for improving venous hemodynamics and relieving associated symptoms.

show abstract

Comparative analysis of VenaBlock and VenaSeal Systems for catheter-guided endovenous cyanoacrylate closure in treating chronic venous insufficiency of the lower extremity: effectiveness and feasibility

BOZKURT,

BALKANAY,

DINC

2024

Int Angiol

View full text Add to dashboard Cite

A comparison of the safety and efficacy of the VenaBlock cyanoacrylate-based endovenous system versus 1470 nm endovascular biradial laser in the treatment of truncal insufficiency of superficial veins: six-month outcomes of the ESVETIS observational study

Cited by 4 publications

References 8 publications

Catheter-guided endovenous cyanoacrylate closure is effective and safe in chronic venous insufficiency of the lower extremity: A Comparative Analysis

Catheter-guided endovenous cyanoacrylate closure is effective and safe in chronic venous insufficiency of the lower extremity: A Comparative Analysis

Endovenous glue ablation for chronic venous insufficiency: A comprehensive 5-year assessment of clinical and hemodynamic outcomes

Comparative analysis of VenaBlock and VenaSeal Systems for catheter-guided endovenous cyanoacrylate closure in treating chronic venous insufficiency of the lower extremity: effectiveness and feasibility

Contact Info

Product

Resources

About